Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Immerse yourself in the latest information, approaches and successes from industry

Introducing this year’s 4 streams….

Stream1: Manufacturing, Process Development, Automation and Cold Chain
  • Get top tips on the application of process automation and closed systems in manufacturing
  • Dive into costs of goods calculations and considerations
Stream 2: Upstream, Downstream, PAT and Analytics
  • Increasing yield, ensuring efficient purification steps and building real-time monitoring into your process- What's new?
  • Get a refresher on analytical testing, quality systems, raw materials and CMC considerations
Stream 3: Preclinical Strategies
  • Get the latest on current development pipelines – discover predictive biomarkers, optimise preclinical models and examine novel targets
  • Pick up knowledge on pre-clinical regulatory and process considerations for entering the clinic
Stream 4: Clinical Development
  • Immerse yourself in potency assays – ensure the right mode of action and characteristics

  • Understand the link between process development and GMP production

Cell Therapy Manufacturing and Gene Therapy Plenaries

Day 1: Opening Plenary

Start the day with a global update on the realities of manufacturing and commercialising CAR-T cells and gene therapies

  • Who is going to win the CAR-T race?
  •  Patient centricity when considering post approval needs for a cell and gene therapy
Day 1: Closing Plenary

Come together at the end of Day 1 for an inspirational talk on the barriers being broken in the bioprinting of human organs

Day 2: Morning Plenary

Our final plenary examines the current regulatory hurdles facing those in the industry…

  • What are the current regulatory challenges in ATMP development
  • A closer look at the proposed global changes to requirements surrounding GMP inspections – expectations and impact